Merger and Acquisition Scenario
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) and Barr Pharmaceuticals, Inc. (BRL)
| Date: | Dec 20, 2008 |
|---|---|
| Format: | HTML |
| Price: | $250.00 |
Abstract
Revere Data's Merger & Acquisition Scenario Report offers independent, objective and insightful analysis into a hypothetical combination of Teva Pharmaceutical Industries Ltd (ADR) (TEVA) with Barr Pharmaceuticals, Inc. (BRL) . The Revere report begins by identifying Teva Pharmaceutical Industries Ltd (ADR) products that are either complementary or overlapping to Barr Pharmaceuticals, Inc. products. Teva Pharmaceutical Industries Ltd (ADR) suppliers are then displayed alongside Barr Pharmaceuticals, Inc. suppliers, with overlapping suppliers to both firms highlighted. Dependent suppliers to both companies are also displayed, including the percentage of dependent revenue if known. Top Teva Pharmaceutical Industries Ltd (ADR) customers and top Barr Pharmaceuticals, Inc. customers, including overlapping customers, are also shown. The Revere report then includes key business relationship data in the area of strategic partnerships for each company. Additional content and features include Lines of Business Summaries, Product Summaries, Individual Teva Pharmaceutical Industries Ltd (ADR) Product Line and Barr Pharmaceuticals, Inc. Product Line Details, Teva Pharmaceutical Industries Ltd (ADR) Earnings and Barr Pharmaceuticals, Inc. Earnings Summaries, and pro forma financial statements. Revere Data Merger & Acquisition Scenario Reports are an essential source of competitive insight into an array of potential merger, acquisition, takeover, consolidation, rollup or other combination scenarios, with particular focus in the healthcare, biotechnology, information technology, finance and media sectors. Revere's extensive databases on key business relationships, product lines, focused sectors, and financial performance indicators provide a rich and integrated information source for investment banking, corporate finance, C-level executives, management consultants, marketing, and business intelligence professionals who want actionable answers and ideas in seconds.
Report Contents
- Summary
- Lines of Business Summary
- Product Summary
- Overlap & Complementary Sectors
- Sample Products in Similar Lines of Business
- Sample Products in Complementary Lines of Business
- Business Relationship Summary
- Top Key Suppliers
- Top Key Customers
- Key Financial Summary
- Individual Company Summary
- Focused Sector
- Revenue/Earnings Summary
- Business Description
- Product Summary
- Product Details
- Relationship Details
- Key Competitors
- Dependent Suppliers
- Key Customers
- Key Partners
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
Companies Mentioned in the Report
- Barr Pharmaceuticals Inc (?203155) - Overview - Reports
- Teva Pharmaceutical Industries Ltd (ADR) (TEVA) - Overview - Reports
More Information:
Learn more about Merger and Acquisition Scenario Report.
Don't see the Scenario report you want? Request Merger and Acquisition Scenario Report »
Download Fact Sheet Merger and Acquisition Scenario (PDF)
Related Reports:
- Merger and Acquisition Scenario for Barr Pharmaceuticals, Inc. (BRL) and VIVUS, Inc. (VVUS)
- Merger and Acquisition Scenario for Barr Pharmaceuticals, Inc. (BRL) and Watson Pharmaceuticals, Inc. (WPI)
- Merger and Acquisition Scenario for Barr Pharmaceuticals, Inc. (BRL) and Alnylam Pharmaceuticals, Inc. (ALNY)
- Merger and Acquisition Scenario for Barr Pharmaceuticals, Inc. (BRL) and Emergent BioSolutions Inc. (EBS)